Thank you.
Professor Gagnon, I found your comments on drug patent subsidies very interesting. You estimate that the return is around $614 million but that we pay $1.7 billion.
We have heard comments and suggestions related to the negotiations between Canada and the European Union saying that the European Union insists that we extend the lifetime of their drug patents.
What are your comments on the potential impact of such a decision on the Canadian government's behalf?